You are viewing the "Sydney Lupkin | NPR" Archives
Pfizer’s RSV vaccine to protect babies gets greenlight from FDA
By: Sydney Lupkin | NPR
Posted on:
WASHINGTON (NPR) — The Food and Drug Administration has approved the first RSV vaccine for expectant mothers aimed at protecting their newborn babies. Given during the third trimester of pregnancy,… Read More
Is it time for a reality check on rapid COVID tests?
By: Sydney Lupkin | NPR
Posted on:
WASHINGTON, D.C. (NPR) — As the COVID-19 pandemic enters its fourth year, a negative result on a little plastic at-home test feels a bit less comforting than it once did…. Read More
What To Know About Those $200 Drug Cards President Trump Promised
By: Sydney Lupkin | NPR
Posted on:
Health policy researchers say Trump may not be able to pay for the cards, which fall short of lasting policy changes to curb high drug prices.
U.S. To Get 100 Million Doses of Pfizer Coronavirus Vaccine In $1.95 Billion Deal
By: Sydney Lupkin | NPR
Posted on:
If the company’s vaccine candidate pans out, Americans can receive it for free, under the deal. The arrangement is part of the U.S. government’s push to have a vaccine widely available by January.
‘Meaningless’ FDA Certificates Are Used To Tout Dubious Face Masks
By: Sydney Lupkin | NPR
Posted on:
Companies that made hats, socks and teddy bears have started producing surgical masks to protect people from COVID-19. Some sellers exaggerate their standing with the Food and Drug Administration.
Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
By: Sydney Lupkin | NPR
Posted on:
On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences’ lobbying hit a new high in the first quarter.